logo

For the Inventor, By the Inventor

Ann Arbor, MI, United States of America

Elizabeth G Nabel

This inventor holds 20 USPTO granted patents, plus 1 CIPO patent. Top assignees: University of Michigan, Vical Incorporated. Active years: 1994-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elizabeth G Nabel. Retrieved from https://idiyas.com/inventor/elizabeth-g-nabel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20

% Patents Active = 85.0

 

Average Co-Inventor Count = 2.4

ph-index = 10

Forward Citations = 791(Granted Patents)


Location History:

  • Ann Arbor, MI (US) (1994 - 2007)
  • Washington, DC (US) (2001 - 2008)

Company Filing History:

goldMedal19 out of 3,536 
 
University of Michigan
 patents
silverMedal1 out of 64 
 
Vical Incorporated
 patents

Years Active: 1994-2008

Loading Chart...
Loading Chart...
20 patents (USPTO):Explore Patents
1. 7414035 - hKIS composition and methods of use (2008-08-19),
2. 7238673 - Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor (2007-07-03),
3. 7226589 - Treatment of diseases by site specific instillation of cells or site specific transformation of cells and kits therefor (2007-06-05),
4. 7087582 - Combination for site-specifically transforming cells in vivo comprising a double-balloon catheter and nucleic acid comprising a gene encoding P21 (2006-08-08),
5. 6979677 - Inhibition of vascular smooth muscle cell proliferation (2005-12-27),
6. 6894154 - hKIS compositions and methods of use (2005-05-17),
7. 6884431 - Method for treating proliferative diseases with p27 and fusions thereof (2005-04-26),
8. 6818016 - Methods for coating stents with DNA and expression of recombinant genes from DNA coated stents in vivo (2004-11-16),
9. 6780406 - Inhibition of vascular smooth muscle cell proliferation administering a thymidine kinase gene (2004-08-24),
10. 6770473 - hKIS compositions and methods of use (2004-08-03),
11. 6297219 - Site-specific instillation of cells or site-specific transformation of cells and kits therefor (2001-10-02),
12. 6218372 - Methods for treating restenosis with p21 (2001-04-17),
13. 6203991 - Inhibition of smooth muscle cell migration by heme oxygenase I (2001-03-20),
14. 6177272 - Method for treating vascular proliferative diseases with p27 and fusions thereof (2001-01-23),
15. 6057300 - Methods for treating cancers and restenosis with p21 (2000-05-02),

Title: Elizabeth G. Nabel: Pioneering Innovation in Cell Proliferation and Tumor Treatment

Introduction

Elizabeth G. Nabel is a prominent inventor based in Ann Arbor, MI, recognized for her significant contributions to biomedical research and therapeutic innovations. With a remarkable portfolio of 20 patents, Dr. Nabel is a leading figure in developing methods and compositions aimed at altering cell proliferation and treating solid tumors.

Latest Patents

One of her latest inventions is a patent titled "hKIS composition and methods of use," which discloses novel compositions and methods for altering the proliferation of cells. This patent includes wild-type and mutant hKIS polypeptides alongside cyclin kinase inhibitors that resist inhibition by serine/threonine kinases. Additionally, another notable patent describes methods for the direct in vivo transformation of cells in and around solid tumors. This innovative approach involves site-specific delivery of proteins through the direct injection of nucleic acid sequences, aimed at facilitating the transfer of vectors and the expression of recombinant genes in the targeted tissue, thus advancing therapeutic and diagnostic techniques for various diseases.

Career Highlights

Elizabeth G. Nabel has had an illustrious career, contributing her expertise to esteemed organizations such as the University of Michigan and Vical Incorporated. Her work has significantly advanced the field of cell and molecular biology, particularly in the context of cancer treatment and cell therapy.

Collaborations

Throughout her career, Dr. Nabel has collaborated with notable colleagues, including Gary J. Nabel and Zhi-yong Yang. These partnerships have fostered innovative approaches and enhanced research capabilities, contributing to the successful development of her patented technologies.

Conclusion

Dr. Elizabeth G. Nabel’s innovative work in the field of biomedical research exemplifies the impact of dedicated inventors in transforming therapeutic practices. Her contributions continue to shape the landscape of cell proliferation and cancer treatment, highlighting her status as a leading inventor in her field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…